BUYER EDUCATION
How to compare taVNS devices.
A device comparison covers the stimulation approach, controls, evidence scope, safety information, regulatory status, and current availability.
Source review · 19 October 2026 · Educational content
COMPARISON FRAMEWORK
Six points of comparison.
- Stimulation location“Vagus nerve stimulation” can refer to implanted, cervical, or auricular approaches. The interface and anatomical location define the method.
- Disclosed parametersUse instructions, parameter ranges, and program definitions describe the protocol. Mode count alone does not establish results.
- Control architectureStimulation control may reside on the device, in an app, or across both; safety functions can follow a different architecture.
- Evidence scopeGeneral taVNS research is useful context, but it is not automatically evidence for a named device.
- Regulatory statusIntended use and market authorization vary by region. Development status does not indicate certification or availability.
- Undisclosed detailsPricing, launch dates, battery life, dimensions, and in-box contents remain unknown until published.
NEUROTHAW DISCLOSURE
What is confirmed today.
NeuroThaw is developing two left-ear taVNS configurations. A is the entry-level standalone design. B adds right-ear PPG and app information synchronization. Neither configuration has an announced certification, market authorization, price, availability, or launch date.
Compare NeuroThaw A and B →GENERAL RESEARCH SOURCES
Further reading.
These independent reviews provide context for the technology area. They are not evidence for NeuroThaw products.
FREQUENTLY ASKED QUESTIONS
Short answers, clear boundaries.
What should I compare between taVNS devices?
Compare the stimulation location, disclosed parameters, controls, safety information, evidence that is specific to the device, regulatory status in your region, and product availability.
Does having more programs mean better clinical performance?
Not necessarily. A program count describes an interface or configuration; it does not by itself establish safety, effectiveness, or suitability.
Can an app replace device-level safety controls?
An app and the device can have different roles. Buyers should look for a clear explanation of where stimulation control and safety functions reside.
Are NeuroThaw A and B certified or available?
No certification, market authorization, availability, pricing, or launch date has been announced for either configuration.